Oncology & Cancer

Breast cancer recurrence score has different implications for men

The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test. The study indicated that chemotherapy ...

Oncology & Cancer

Men with breast cancer face high mortality rates: Study

Men with breast cancer are more likely to die than their female counterparts, across all stages of disease, with the disparity persisting even when clinical characteristics, such as cancer types, treatment and access to care ...

Oncology & Cancer

Ibrance approval expanded to include men with breast cancer

(HealthDay)—U.S. Food and Drug Administration approval of Ibrance (palbociclib) capsules has been widened to include men with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic ...

Oncology & Cancer

Stop marginalising men with breast cancer

Breast cancer is the most common cancer in the UK and the leading cancer in women worldwide. Approximately 150 cases are diagnosed in the UK every day – that's one every 10 minutes. Breast cancer does not discriminate. ...

page 1 from 4